Cellect Biotechnology (Cellect Biotechnology) Net Income (Continuing Operations) : $-3.31 Mil (TTM As of Jun. 2021)

View and export this data going back to 2016. Start your Free Trial

What is Cellect Biotechnology Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Cellect Biotechnology's Net Income (Continuing Operations) for the three months ended in Jun. 2021 was $-1.50 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2021 was $-3.31 Mil.

Cellect Biotechnology Net Income (Continuing Operations) Historical Data

The historical data trend for Cellect Biotechnology's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellect Biotechnology Net Income (Continuing Operations) Chart

Cellect Biotechnology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-4.12

-7.58

-5.40

-4.52

-4.86

Cellect Biotechnology Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Jun21
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-0.69	-2.37	-0.44	-1.37	-1.50

Cellect Biotechnology Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.31 Mil.

Cellect Biotechnology (NAS:APOP) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Cellect Biotechnology Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Cellect Biotechnology's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Cellect Biotechnology (Cellect Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellect Biotechnology Ltd (NAS:APOP) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

23 Hata’as Street, Kfar Saba, ISR, 44425

Website

http://www.cellect.co

Cellect Biotechnology Ltd is a biotechnology company that has developed a novel technology platform known as ApoGraft that functionally selects cells in order to improve the safety and efficacy of regenerative medicine and cell therapies. The company is developing its first product based on its ApoGraft technology platform, the ApoTainer kit that utilizes FasL- apoptotic protein.